The pervasive connectivity fabric of 5G
5G is not just another connectivity technology.
It brings a unique ability to embed ultra-reliable, ultra-fast, and machine-scale connectivity deeply into the transformational industry capabilities. The pervasive connectivity fabric of 5G reinforces technology advances in augmented reality (AR), virtual reality (VR), artificial intelligence (AI), industry automation, autonomous vehicles, and smart cities. 5G technology will significantly impact the life sciences industry as the focus now shifts to patient-centricity and evidence-based healthcare outcomes.
Digital tech driving 5G adoption
As industries embrace emerging technologies, we witness why a private 5G network is pivotal to enabling emergent tech success. Technologies such as XR and the metaverse, quantum computing, and robotics depend on the benefit of connectivity. They also need some of the granular capabilities of 5G to deliver value and experience, to both consumers and enterprises.
For life sciences companies, the 5G network and its capabilities of reliability, ultra-high speed, and low latency service will open new avenues for robots and collaborative bots. It will be challenging to execute discreet automation use cases, especially, in a man-machine environment without 5G.
Four pillars of 5G that make it integral for life sciences industry transformation
5G is compelling to technologists, futurists, and enterprise strategy planners.
Private 5G will unlock new generation of industry use cases from digital surgery and precision medicine to autonomous warehouses and factories.
The four pillars upon which any 5G use case rests include the following:
5G is elastic, just like cloud technology, a critical determinant for the success of use cases like digital surgery where surgery applications dynamically orchestrate the network capacity and the characteristic it needs without any impact on the end outcomes.
5G is programmable and allows life sciences industries to build applications like a robotic surgical arm, to directly invoke, and control network using APIs.
The art of the possible in life sciences
5G will have a transformative impact on the life sciences industry.
It equips companies with a whole lot of new capabilities, such as:
Exploring patient-centric outcomes with 5G
The next step is to build use cases and evaluate 5G capabilities in the life sciences industry.
Unlike the past era of connectivity technologies, 5G with an edge, interoperability offers enterprises the flexibility to create tailor-made connectivity architecture suitable for business needs. Life sciences industries need to evaluate 5G capabilities and the connectivity strategy in the context of industry capabilities and patient-centric outcomes they seek to deliver.